Home▸Articles▸MASLD/NAFLD — Non-Alcoholic Fatty Liver Disease

Understanding the FIB-4 & NAFLD Fibrosis Score Calculator

A critical tool in non-invasive assessment of liver fibrosis for diagnosing and monitoring Non-Alcoholic Fatty Liver Disease (NAFLD).

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What is the FIB-4 Score?

The FIB-4 score is a non-invasive method for assessing the degree of liver fibrosis in patients with suspected Non-Alcoholic Steatohepatitis (NASH) or other chronic liver conditions. It combines four easily obtainable laboratory parameters: age, alanine transaminase (ALT), aspartate transaminase (AST), and platelet count.

The FIB-4 score is calculated using the formula: FIB-4 = (97.5 * ln(ALT) + 3.29 * (Age - 10) - 7.64 * ln(Platelets)) / 4.63, where ALT and platelet counts are in international units per liter (IU/L), age is in years.

How Does the FIB-4 Score Work?

The FIB-4 score quantifies liver fibrosis based on a combination of biochemical markers. Elevated levels of ALT and AST indicate inflammation or damage, while a lower platelet count suggests increased liver stiffness due to fibrosis.

The threshold values for the FIB-4 score are used to categorize patients into different stages of fibrosis: <1.35 (low risk), 1.35-2.29 (moderate risk), and ≥2.29 (high risk). These thresholds help guide further diagnostic steps, such as liver biopsy or non-invasive elastography.

live demo · related simulation● LIVE

Why is the FIB-4 Score Important?

The FIB-4 score provides a quick and reliable method to screen for liver fibrosis without the need for invasive procedures like liver biopsies. This makes it an essential tool in managing NAFLD, which can progress to more severe conditions such as NASH and cirrhosis.

By identifying patients at higher risk of advanced fibrosis early, healthcare providers can implement targeted interventions aimed at slowing or reversing disease progression.

Real-World Applications

The FIB-4 score is widely used in clinical practice to monitor the effectiveness of treatments for NAFLD and NASH. It helps in assessing whether lifestyle changes, medications, or other therapies are having a positive impact on liver health.

Additionally, it aids in research studies by providing a standardized method to compare fibrosis stages across different populations and treatment groups.

Frequently asked questions

What is NAFLD and how common is it?

NAFLD stands for Non-Alcoholic Fatty Liver Disease, which refers to the accumulation of fat in liver cells. It affects approximately 25% of adults globally and can progress to more severe conditions like NASH (Non-Alcoholic Steatohepatitis).

How accurate is the FIB-4 score compared to a liver biopsy?

The FIB-4 score has been shown to have good accuracy in predicting liver fibrosis stages, with an area under the ROC curve (AUC) of around 0.85. However, it should be used as a screening tool and not replace liver biopsies for definitive diagnosis.

Can the FIB-4 score be used in children?

The FIB-4 score is primarily validated for use in adults. For pediatric patients, alternative scoring systems such as the APRI (Aspartate Aminotransferase to Platelet Ratio Index) are often used.

What other non-invasive methods can be used alongside the FIB-4 score?

Other non-invasive methods include transient elastography techniques like FibroScan, which measures liver stiffness, and MRI-based methods such as MRE (Magnetic Resonance Elastography). These methods complement the FIB-4 score in providing a comprehensive assessment of liver fibrosis.

Try it live

Everything above runs in your browser — open FIB-4 & NAFLD Fibrosis Score Calculator Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open FIB-4 & NAFLD Fibrosis Score Calculator Simulator simulation

What did you find?

Add reproduction steps (optional)